<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="occasional outbreaks of emerging and re-emerging viral diseases such as" exact="Dengue" post="fever, West Nile Fever, Zika virus disease, Chikungunya disease,"/>
 <result pre="of emerging and re-emerging viral diseases such as Dengue fever," exact="West Nile" post="Fever, Zika virus disease, Chikungunya disease, Middle east respiratory"/>
 <result pre="re-emerging viral diseases such as Dengue fever, West Nile Fever," exact="Zika" post="virus disease, Chikungunya disease, Middle east respiratory syndrome, Ebola"/>
 <result pre="such as Dengue fever, West Nile Fever, Zika virus disease," exact="Chikungunya" post="disease, Middle east respiratory syndrome, Ebola virus disease and"/>
 <result pre="There is no clear idea whether emerging viruses such as" exact="Zika" post="virus, Ebola virus, West Nile virus, Dengue virus and"/>
 <result pre="idea whether emerging viruses such as Zika virus, Ebola virus," exact="West Nile" post="virus, Dengue virus and many others owe part of"/>
 <result pre="viruses such as Zika virus, Ebola virus, West Nile virus," exact="Dengue" post="virus and many others owe part of their evolution"/>
 <result pre="as emerging and re-emerging pathogens such as dengue virus (DENV)," exact="West Nile" post="Virus (WNV), Zika Virus (ZIKV) and these viruses pose"/>
 <result pre="pathogens such as dengue virus (DENV), West Nile Virus (WNV)," exact="Zika" post="Virus (ZIKV) and these viruses pose a global threat"/>
 <result pre="NS2A, NS2B and NS4A and NS4B (Figure 2B) [33]. 3.1." exact="Dengue" post="Virus (DENV) Dengue is a re-emerging arboviral infection transmitted"/>
 <result pre="NS4A and NS4B (Figure 2B) [33]. 3.1. Dengue Virus (DENV)" exact="Dengue" post="is a re-emerging arboviral infection transmitted by Aedes mosquitoes"/>
 <result pre="and 25,000 deaths yearly [37]. A previous study compared a" exact="DENV" post="vaccine candidate strain, DENV-3 PGMK30FRhL3 (PGMK30), which produced acute"/>
 <result pre="(PGMK30), which produced acute febrile illnesses with another clinically safe" exact="DENV" post="vaccine candidate DENV-2PDK53 (PDK53). Using in vitro and in"/>
 <result pre="gene sequence was investigated using the plasma samples of six" exact="DENV" post="infected patients. The first account of viral quasispecies of"/>
 <result pre="DENV infected patients. The first account of viral quasispecies of" exact="DENV" post="in vivo was reported using clonal sequencing analysis whereby"/>
 <result pre="of quasispecies could lead to the rational design of a" exact="DENV" post="vaccine. 3.2. Zika Virus (ZIKV) Zika Virus was first"/>
 <result pre="lead to the rational design of a DENV vaccine. 3.2." exact="Zika" post="Virus (ZIKV) Zika Virus was first discovered in 1947"/>
 <result pre="rational design of a DENV vaccine. 3.2. Zika Virus (ZIKV)" exact="Zika" post="Virus was first discovered in 1947 when it was"/>
 <result pre="It belongs to the Flavivirus genus within the Flaviviridae family." exact="Zika" post="infections have been reported in Egypt [43], East Africa"/>
 <result pre="mutation was produced using an infectious molecular clone of the" exact="ZIKV" post="MR766 strain. The plaque size produced by the recombinant"/>
 <result pre="and virulence in mice [48]. The quasispecies distribution of a" exact="ZIKV" post="strain (ZIKV-SL1602) isolated from a 29-year-old female traveler was"/>
 <result pre="clade stems from the island of French Polynesia [49]. 3.3." exact="West Nile" post="Virus (WNV) West Nile Virus was first characterized in"/>
 <result pre="island of French Polynesia [49]. 3.3. West Nile Virus (WNV)" exact="West Nile" post="Virus was first characterized in 1937 in the West"/>
 <result pre="West Nile Virus was first characterized in 1937 in the" exact="West Nile" post="district of Uganda and was taxonomically placed in the"/>
 <result pre="spread to other parts of the USA between 1999–2001 [50]." exact="WNV" post="survives naturally in a mosquito-bird-mosquito transmission cycle involving the"/>
 <result pre="small-plaque (SP) variant was picked from a mutant population of" exact="WNV" post="isolated from an American crow in New York in"/>
 <result pre="isolate to the wild-type phenotype [52]. The genetic diversity of" exact="WNV" post="in the avian host was also investigated using next-generation"/>
 <result pre="and wild juvenile carrion crows. Data collected revealed that the" exact="WNV" post="population showed significant heterogeneity diverging from the quasispecies structure"/>
 <result pre="the variations in genetic diversity. It was demonstrated that the" exact="WNV" post="genetic diversifications varied significantly from the inoculum in crows"/>
 <result pre="to genetic diversifications. NGS technologies have enabled the analysis of" exact="WNV" post="quasispecies dynamics, leading to a better understanding of the"/>
 <result pre="four non-structural proteins (NSP1, NSP2, NSP3 and NSP4) (Figure 3B)." exact="Chikungunya" post="Virus (CHIKV) Chikungunya virus (CHIKV) is an arthropod-borne virus"/>
 <result pre="(NSP1, NSP2, NSP3 and NSP4) (Figure 3B). Chikungunya Virus (CHIKV)" exact="Chikungunya" post="virus (CHIKV) is an arthropod-borne virus transmitted to humans"/>
 <result pre="significant human morbidity in many parts of the world [56]." exact="Chikungunya" post="virus causes an acute febrile illness with high fever,"/>
 <result pre="be prolonged from months to years [57,58]. Some cases of" exact="CHIKV" post="disease were associated with neurological complications [59]. The virus"/>
 <result pre="2 million people [60]. The original geographical distributions of the" exact="CHIKV" post="indicated that there are 3 distinct groups and phylogenetic"/>
 <result pre="virus in the Americas [62,64,65,66,67]. Even though a number of" exact="CHIKV" post="vaccine candidates are being developed, no effective vaccine is"/>
 <result pre="[68]. Similar to other RNA viruses with extensive mutation rates," exact="CHIKV" post="produces populations of genetically diverse genomes within a host."/>
 <result pre="al. investigated the intra-host genetic diversity of high and low-fidelity" exact="CHIKV" post="variants using murine models. Both the high and low"/>
 <result pre="low fidelity variants were expected to lower the virulence of" exact="CHIKV" post="as compared to the wild-type (CHIKV-WT). However, the high-fidelity"/>
 <result pre="CHIKV-WT at 3- and 4-days post-infection (dpi). Moreover, the high-fidelity" exact="CHIKV" post="(CHIKV-HiFi) infected mice also displayed higher peaks of disease"/>
 <result pre="In high-fidelity variants, nsp2 G641D and nsp4 C483Y mutations increased" exact="CHIKV" post="virulence in the adult mice. The NGS data showed"/>
 <result pre="is a common feature of viral characterization. Primary isolates of" exact="CHIKV" post="containing variants with different plaque sizes were previously reported"/>
 <result pre="small and large plaques had been reported in the 2005" exact="CHIKV" post="outbreak isolates [72]. It is curious how small plaque"/>
 <result pre="In order to explore the virulence of the small plaque" exact="CHIKV" post="variant in vivo, the pathogenicity of the purified small"/>
 <result pre="the pathogenicity of the purified small plaque variant of the" exact="CHIKV" post="virus isolated from the sera of the patient in"/>
 <result pre="infection with the wild-type virus. The small plaque variant of" exact="CHIKV" post="obtained by plaque purifications exhibited decreased virulence that makes"/>
 <result pre="appropriate to serve as candidates for live-attenuated vaccine development. The" exact="CHIKV" post="variant with the small plaque size formed a major"/>
 <result pre="the small plaque size formed a major subpopulation in the" exact="CHIKV" post="primary isolate during multiple passages in C6/36 cells. This"/>
 <result pre="Comparative sequence alignment of large and small plaque variants of" exact="CHIKV" post="primary isolates from the Comoros Island showed two amino"/>
 <result pre="However, these particular amino acid residues were observed in other" exact="CHIKV" post="isolates previously [71] and the significance of these specific"/>
 <result pre="Abeyratne et al. investigated the role of the capsid in" exact="CHIKV" post="virulence by studying the nucleolar localization sequence (NoLS) [74]."/>
 <result pre="NoLS is a region in the N-terminal part of the" exact="CHIKV" post="capsid protein, between residues 58 and 110 and is"/>
 <result pre="amino acids [75,76]. Mutations in the NoLS capsid of the" exact="CHIKV" post="led to the development of a unique live-attenuated CHIKV"/>
 <result pre="the CHIKV led to the development of a unique live-attenuated" exact="CHIKV" post="vaccine candidate designated as CHIKV-NoLS. The P5 CHIKV-NoLS clone"/>
 <result pre="the CHIKV-NoLS-immunized mice were able to produce long-term immunity against" exact="CHIKV" post="infection following immunization with a single dose of the"/>
 <result pre="in immunized mice and produced sera which could effectively neutralize" exact="CHIKV" post="infection in vitro, it could serve as a promising"/>
 <result pre="vaccine candidate needed to control the explosive large-scale outbreaks of" exact="CHIKV" post="[76]. 5. Filoviridae Viruses found within the Filoviridae family"/>
 <result pre="and Severe DengueAvailable online: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue(accessed on 15 April 2019) 36.HenchalE.A.PutnakJ.R.The" exact="Dengue" post="virusesClin. Microbiol. Rev.1990337639610.1128/CMR.3.4.3762224837 37.WhitehornJ.SimmonsC.P.The pathogenesis of DengueVaccine2011297221722810.1016/j.vaccine.2011.07.02221781999 38.GohK.C.M.TangC.K.NortonD.C.GanE.S.TanH.C.SunB.SyeninaA.YousufA.OngX.M.KamarajU.S.et al.Molecular"/>
 <result pre="38.GohK.C.M.TangC.K.NortonD.C.GanE.S.TanH.C.SunB.SyeninaA.YousufA.OngX.M.KamarajU.S.et al.Molecular determinants of plaque size as an indicator of" exact="Dengue" post="virus attenuationSci. Rep.201662610010.1038/srep2610027185466 39.WangW.-K.LinS.-R.LeeC.-M.KingC.-C.ChangS.-C.Dengue type 3 virus in plasma"/>
 <result pre="closely related genomes: quasispeciesJ. Virol.2002764662466510.1128/JVI.76.9.4662-4665.200211932434 40.ParameswaranP.WangC.TrivediS.B.EswarappaM.MontoyaM.BalmasedaA.HarrisE.Intrahost selection pressures drive rapid" exact="Dengue" post="virus microevolution in acute human infectionsCell Host Microbe20172240041010.1016/j.chom.2017.08.00328910637 41.LoveH.Investigation"/>
 <result pre="J. Hyg.19545915716313138582 48.KatoF.TajimaS.NakayamaE.KawaiY.TaniguchiS.ShibasakiK.TairaM.MaekiT.LimC.K.TakasakiT.Characterization of large and small-plaque variants in the" exact="Zika" post="virus clinical isolate ZIKV/Hu/S36/Chiba/2016Sci. Rep.201771616010.1038/s41598-017-16475-229170504 49.van BoheemenS.TasA.AnvarS.Y.van GrootveldR.AlbulescuI.C.BauerM.P.FeltkampM.C.BredenbeekP.J.van HemertM.J.Quasispecies"/>
 <result pre="49.van BoheemenS.TasA.AnvarS.Y.van GrootveldR.AlbulescuI.C.BauerM.P.FeltkampM.C.BredenbeekP.J.van HemertM.J.Quasispecies composition and evolution of a typical" exact="Zika" post="virus clinical isolate from SurinameSci. Rep.20177236810.1038/s41598-017-02652-w28539654 50.CampbellG.L.MarfinA.A.LanciottiR.S.GublerD.J.West Nile VirusLancet"/>
 <result pre="50.CampbellG.L.MarfinA.A.LanciottiR.S.GublerD.J.West Nile VirusLancet Infect. Dis.2002251952910.1016/S1473-3099(02)00368-712206968 51.TurellM.J.SardelisM.R.DohmD.J.O’GuinnM.L.Potential North American vectors of" exact="West Nile" post="virusAnn. N. Y. Acad. Sci.200195131732410.1111/j.1749-6632.2001.tb02707.x11797788 52.JiaY.MoudyR.M.DupuisA.P.NgoK.A.MaffeiJ.G.JerzakG.V.FrankeM.A.KauffmanE.B.KramerL.D.Characterization of a small"/>
 <result pre="Y. Acad. Sci.200195131732410.1111/j.1749-6632.2001.tb02707.x11797788 52.JiaY.MoudyR.M.DupuisA.P.NgoK.A.MaffeiJ.G.JerzakG.V.FrankeM.A.KauffmanE.B.KramerL.D.Characterization of a small plaque variant of" exact="West Nile" post="virus isolated in New York in 2000Virology200736733934710.1016/j.virol.2007.06.00817617432 53.DridiM.RosseelT.OrtonR.JohnsonP.LecollinetS.MuylkensB.LambrechtB.Van BormS.Next-generation"/>
 <result pre="isolated in New York in 2000Virology200736733934710.1016/j.virol.2007.06.00817617432 53.DridiM.RosseelT.OrtonR.JohnsonP.LecollinetS.MuylkensB.LambrechtB.Van BormS.Next-generation sequencing shows" exact="West Nile" post="virus quasispecies diversification after a single passage in a"/>
 <result pre="Primates in Biomedical ResearchAbeeC.MansfieldK.TardifS.MorrisT.Academic PressCambridge, MA, USA2012Volume 21104 56.WeaverS.C.Arrival of" exact="Chikungunya" post="virus in the new world: prospects for spread and"/>
 <result pre="J. Infect. Dis.201115e671e67610.1016/j.ijid.2011.06.00221775183 63.SreekumarE.IssacA.NairS.HariharanR.JankiM.B.ArathyD.S.ReguR.MathewT.AnoopM.NiyasK.P.et al.Genetic characterization of 2006–2008 isolates of" exact="Chikungunya" post="virus from Kerala, South India, by whole genome sequence"/>
 <result pre="analysisVirus Genes2009401410.1007/s11262-009-0411-919851853 64.SudeepA.ParasharD.Chikungunya: an overviewJ. Biosci.20083344344910.1007/s12038-008-0063-219208970 65.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="Chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 66.ShalauddinA.LorraineF.RickettsR.P.TrudyC.KarenP.-E.BabatundeO.Chikungunya"/>
 <result pre="Pathog.20073e20110.1371/journal.ppat.003020118069894 66.ShalauddinA.LorraineF.RickettsR.P.TrudyC.KarenP.-E.BabatundeO.Chikungunya virus outbreak, Dominica, 2014Emerging Infect. Dis.20152190925898214 67.SamI.C.KümmererB.M.ChanY.-F.RoquesP.DrostenC.AbuBakarS.Updates on" exact="Chikungunya" post="epidemiology, clinical disease and diagnosticsVector Borne Zoonotic Dis.20151522323010.1089/vbz.2014.168025897809 68.PowersA.M.Vaccine"/>
 <result pre="diagnosticsVector Borne Zoonotic Dis.20151522323010.1089/vbz.2014.168025897809 68.PowersA.M.Vaccine and therapeutic options to control" exact="Chikungunya" post="virusClin. Microbiol. Rev.20183110.1128/CMR.00104-16 69.RiemersmaK.K.SteinerC.SingapuriA.CoffeyL.L.Chikungunya virus fidelity variants exhibit differential"/>
 <result pre="with different characteristicsAm. J. Trop. Med. Hyg.20098186586810.4269/ajtmh.2009.09-000919861623 71.WasongaC.InoueS.RumberiaC.MichukiG.KimothoJ.OngusJ.R.SangR.MusilaL.Genetic divergence of" exact="Chikungunya" post="virus plaque variants from the Comoros Island (2005)Virus Genes20155132332810.1007/s11262-015-1243-426347221"/>
 <result pre="variants from the Comoros Island (2005)Virus Genes20155132332810.1007/s11262-015-1243-426347221 72.SergonK.YahayaA.A.BrownJ.BedjaS.A.MlindasseM.AgataN.AllarangerY.BallM.D.PowersA.M.OfulaV.et al.Seroprevalence of" exact="Chikungunya" post="virus infection on Grande Comore Island, union of the"/>
 <result pre="2005Am. J. Trop. Med. Hyg.2007761189119310.4269/ajtmh.2007.76.118917556634 73.JaimipakT.YoksanS.UbolS.PulmanausahakulR.Small plaque size variant of" exact="Chikungunya" post="primary isolate showed reduced virulence in miceAsian Pac. J."/>
 <result pre="J. Allergy Immunol.20183620120528938842 74.AbeyratneE.FreitasJ.R.ZaidA.MahalingamS.TaylorA.Attenuation and stability of CHIKV-NoLS, a live-attenuated" exact="Chikungunya" post="virus vaccine candidateVaccines20187210.3390/vaccines701000230583514 75.FavreD.StuderE.MichelM.Two nucleolar targeting signals present in"/>
 <result pre="virus capsid proteinArch. Virol.199413714915510.1007/BF013111817979988 76.TaylorA.LiuX.ZaidA.GohL.Y.H.Hobson-PetersJ.HallR.A.MeritsA.MahalingamS.Mutation of the N-terminal region of" exact="Chikungunya" post="virus capsid protein: implications for vaccine designMBio20178e01970-1610.1128/mBio.01970-1628223458 77.LeeS.OwenK.E.ChoiH.-K.LeeH.LuG.WenglerG.BrownD.T.RossmannM.G.KuhnR.J.Identification of"/>
</results>
